At FCE Pharma (November 30 - December 2, 2021; São Paulo) Datwyler, (Booth G098) will highlight its high-quality, system-critical elastomer components for injectable drugs such as the COVID-19 vaccine. Since the start of the pandemic, Datwyler has supplied system-critical components including stoppers and aluminum seals to vaccine developers around the world.
As Latin American countries work to meet vaccine needs for COVID-19 and beyond, Datwyler has mobilized its global manufacturing resources to support vaccine providers by supplying vaccine components from its plants around the world, including those in the United States, Italy, Belgium, Germany and India.
With its expanded network of FirstLine™ manufacturing facilities including a new plant in Middletown, US, and enlarged capacities at its Indian plant, which marry best-in-class production technologies with fully integrated cleanroom environments, the company provides critical infrastructure to support the fluctuating demand around COVID-19. This past year, Datwyler was recognized by BioNTech as one of its crucial partners in supporting the development of a vaccine for COVID-19.